Rhythm Pharmaceuticals Inc (RYTM) support and resistance · rev $130.1M
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
This page maps Rhythm Pharmaceuticals Inc (RYTM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
RYTM currently screens at market cap $6.49B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RYTM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RYTM quote page for the session range and the stock page for the full model.
Not investment advice.